BRPI0112411B8 - uso de isolados de vírus parapox inativado - Google Patents

uso de isolados de vírus parapox inativado

Info

Publication number: BRPI0112411B8
Authority: BR; Brazil
Prior art keywords: virus isolates; orf; strains; medicament; parapox virus
Prior art date: 2000-07-11

Application number

Other languages

English (en)

Portuguese (pt)

Inventor

Knorr Andreas

Siegling Angela

Hirth-Dietrich Claudia

Theiss Gudrun

Weber Olaf

Schlapp Tobias

Original Assignee

Aicuris Gmbh & Co Kg

Bayer Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-11

Filing date

2001-07-11

Publication date

2021-05-25

2001-07-11 Application filed by Aicuris Gmbh & Co Kg, Bayer Ag filed Critical Aicuris Gmbh & Co Kg

2001-07-11 Priority claimed from PCT/EP2001/007978 external-priority patent/WO2002004019A2/de

2003-05-27 Publication of BR0112411A publication Critical patent/BR0112411A/pt

2018-02-27 Publication of BRPI0112411B1 publication Critical patent/BRPI0112411B1/pt

2021-05-25 Publication of BRPI0112411B8 publication Critical patent/BRPI0112411B8/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24211—Parapoxvirus, e.g. Orf virus
- C12N2710/24232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24211—Parapoxvirus, e.g. Orf virus
- C12N2710/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24211—Parapoxvirus, e.g. Orf virus
- C12N2710/24261—Methods of inactivation or attenuation
- C12N2710/24264—Methods of inactivation or attenuation by serial passage

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Addiction (AREA)
Biotechnology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Wood Science & Technology (AREA)
General Engineering & Computer Science (AREA)
Neurology (AREA)
Dermatology (AREA)
Biochemistry (AREA)
Physical Education & Sports Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Psychiatry (AREA)
Molecular Biology (AREA)
Neurosurgery (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

BRPI0112411-0 2000-07-11 2001-07-11 uso de isolados de vírus parapox inativado BRPI0112411B8 (pt)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
DE10033581.0		2000-07-11
DE10033581		2000-07-11
DE10122233A DE10122233A1 (de)	2000-07-11	2001-05-08	Verwendung von Stämmen des Parapoxvirus ovis gegen Organfibrosen
DE10122233.5		2001-05-08
PCT/EP2001/007978 WO2002004019A2 (de)	2000-07-11	2001-07-11	Verwendung von stämmen des parapoxvirus ovis gegen organfibrosen

Publications (3)

Publication Number	Publication Date
BR0112411A BR0112411A (pt)	2003-05-27
BRPI0112411B1 BRPI0112411B1 (pt)	2018-02-27
BRPI0112411B8 true BRPI0112411B8 (pt)	2021-05-25

Family

ID=7648485

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0112411-0 BRPI0112411B8 (pt)	2000-07-11	2001-07-11	uso de isolados de vírus parapox inativado

Country Status (14)

Country	Link
JP (2)	JP5587950B2 (de)
KR (1)	KR100845643B1 (de)
CN (1)	CN101444539B (de)
AT (1)	ATE445413T1 (de)
BR (1)	BRPI0112411B8 (de)
DE (2)	DE10122233A1 (de)
DK (1)	DK1303302T3 (de)
DO (1)	DOP2001000210A (de)
EC (1)	ECSP034420A (de)
ES (1)	ES2332355T3 (de)
PE (1)	PE20020218A1 (de)
PT (1)	PT1303302E (de)
SV (1)	SV2002000527A (de)
ZA (1)	ZA200300276B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102015111756A1 (de) *	2015-07-20	2017-01-26	Eberhard Karls Universität Tübingen Medizinische Fakultät	Rekombinanter Orf-Virus-Vektor
CA3018307A1 (en)	2016-02-16	2017-08-24	Osaka University	Pharmaceutical composition for use in treating fibrosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4405841C1 (de) *	1994-02-23	1995-01-05	Mayr Anton Prof Dr Med Vet Dr	Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
ES2125846T3 (es) *	1996-04-15	2001-12-16	Anton Prof Dr Med Vet Dr Mayr	Nuevas indicaciones para el empleo de inductores de parainmunidad multipotentes a partir de virus de viruela o virus de paraviruela atenuados, no inmunogenos, como medicamento.

2001
- 2001-05-08 DE DE10122233A patent/DE10122233A1/de not_active Withdrawn
- 2001-07-10 PE PE2001000681A patent/PE20020218A1/es not_active Application Discontinuation
- 2001-07-11 KR KR1020037000310A patent/KR100845643B1/ko not_active Expired - Fee Related
- 2001-07-11 ES ES01965110T patent/ES2332355T3/es not_active Expired - Lifetime
- 2001-07-11 DE DE50115181T patent/DE50115181D1/de not_active Expired - Lifetime
- 2001-07-11 PT PT01965110T patent/PT1303302E/pt unknown
- 2001-07-11 DK DK01965110.8T patent/DK1303302T3/da active
- 2001-07-11 AT AT01965110T patent/ATE445413T1/de active
- 2001-07-11 SV SV2001000527A patent/SV2002000527A/es not_active Application Discontinuation
- 2001-07-11 CN CN200810149856.XA patent/CN101444539B/zh not_active Expired - Lifetime
- 2001-07-11 BR BRPI0112411-0 patent/BRPI0112411B8/pt not_active IP Right Cessation
- 2001-07-11 DO DO2001000210A patent/DOP2001000210A/es unknown
2003
- 2003-01-10 ZA ZA200300276A patent/ZA200300276B/en unknown
- 2003-01-10 EC EC2003004420A patent/ECSP034420A/es unknown
2012
- 2012-06-28 JP JP2012145847A patent/JP5587950B2/ja not_active Expired - Lifetime
2014
- 2014-06-17 JP JP2014124405A patent/JP5950964B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DE10122233A1 (de)	2002-01-24
ES2332355T3 (es)	2010-02-03
BR0112411A (pt)	2003-05-27
CN101444539A (zh)	2009-06-03
DE50115181D1 (de)	2009-11-26
PE20020218A1 (es)	2002-05-19
JP2012214492A (ja)	2012-11-08
DOP2001000210A (es)	2002-12-15
ECSP034420A (es)	2003-03-10
ZA200300276B (en)	2004-04-13
CN101444539B (zh)	2016-07-06
JP2014196329A (ja)	2014-10-16
DK1303302T3 (da)	2010-02-08
PT1303302E (pt)	2009-11-11
KR20030019562A (ko)	2003-03-06
KR100845643B1 (ko)	2008-07-10
SV2002000527A (es)	2002-10-24
JP5587950B2 (ja)	2014-09-10
JP5950964B2 (ja)	2016-07-13
BRPI0112411B1 (pt)	2018-02-27
ATE445413T1 (de)	2009-10-15

Publication	Publication Date	Title
NO312225B2 (no)	2002-04-15	Farmasoytiske preparater av fluoxetin
CY1105127T1 (el)	2009-11-04	Συνθεση για την προληψη καρδιαγγειακων νοσων
YU46012B (sh)	1992-12-21	Postupak za izradu vodenih gelirajućih rastvora derivata arilpropionske kiseline koji mogu da se resporbuju kroz kožu
MXPA02007478A (es)	2004-08-23	Vacuna contra el virus de inmunodeficiencia humana.
WO2001010456A3 (en)	2001-09-20	Peptides that block viral infectivity and methods of use thereof
CA2130360A1 (en)	1993-08-21	Sulfonic Acid Derivatives in the Treatment of Viral Diseases
ATE291908T1 (de)	2005-04-15	Ibuprofen-wirkstoffzubereitung
ES2058418T3 (es)	1994-11-01	Preparacion farmaceutica contra enfermedades viricas que comprende un extracto de higado.
CA2504872A1 (en)	2004-05-21	Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections
BRPI0112411B8 (pt)	2021-05-25	uso de isolados de vírus parapox inativado
ATE374208T1 (de)	2007-10-15	Pharmakologisch aktive antivirale peptide und methoden zu ihrer anwendung
SE0001916D0 (sv)	2000-05-23	Novel formulation
SE9900177D0 (sv)	1999-01-21	Vårtmedel
MXPA05005911A (es)	2005-08-29	Utilizacion del acido docosahexaenoico como sustancia activa para el tratamiento de la lipodistrofia.
TR200200724T2 (tr)	2002-06-21	Cilde sürülebilen farmasötik bileşimlerin antimikrobik etkisinin arttırılması için yağlı asit/amino asit sabunlarının kullanımı
EP1038529A3 (de)	2002-05-02	Wirkstoff zur Erhöhung der Chemokinproduktion
ATE236195T1 (de)	2003-04-15	Entgiftung von pharmazeutischen wirkstoffen durch cyclodextrin-oligomere
MD1473F2 (en)	2000-05-31	Antiherpetic remedy
Hecht	1996	A new focus on primary HIV infection
Vazquez	1996	How low can you go
DK0545991T3 (da)	1999-08-16	Peptider, der blokerer infektioner med human immundefektvirus, og fremgangsmåder til anvendelse deraf
RU2001127052A (ru)	2003-07-27	Штамм вируса Эбола "Заир Ч-15" для проведения модельных экспериментов и приготовления диагностических и вакцинных препаратов
Ishak et al.	2000	A13 Oral infection of Aedes aegypti and Aedes albopictus with Dengue-1 viruses: Susceptibility comparison and molecular analysis
Mishriki	1997	The case of the creeping papules
NO992244L (no)	1999-07-07	AIDS-legemiddel

Legal Events

Date	Code	Title	Description
2007-02-21	B25A	Requested transfer of rights approved	Owner name: AICURIS GMBH AND CO. KG (DE) Free format text: TRANSFERIDO DE: BAYER AKTIENGESELLSCHAFT
2008-08-12	B25G	Requested change of headquarter approved	Owner name: AICURIS GMBH AND CO. KG (DE) Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020070107873/RJ DE 03/08/2007.
2011-01-04	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2012-07-17	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2013-08-20	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2013-10-15	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2014-03-04	B09B	Patent application refused [chapter 9.2 patent gazette]	Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 13, 24, 25 DA LPI
2014-06-24	B12B	Appeal against refusal [chapter 12.2 patent gazette]
2018-02-27	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/07/2001 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF
2022-05-03	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 21A ANUIDADE.
2022-08-23	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2678 DE 03-05-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.